Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Concurrent gliomas in patients with multiple sclerosis

Katharina Sahm, Tobias Kessler, View ORCID ProfilePhilipp Eisele, Miriam Ratliff, Elena Sperk, Laila König, Michael O. Breckwoldt, Corinna Seliger, Iris Mildenberger, Daniel Schrimpf, Christel Herold-Mende, View ORCID ProfilePia S. Zeiner, Ghazaleh Tabatabai, Sven G. Meuth, David Capper, Martin Bendszus, Andreas von Deimling, Wolfgang Wick, View ORCID ProfileFelix Sahm, View ORCID ProfileMichael Platten
doi: https://doi.org/10.1101/2022.07.01.22277047
Katharina Sahm
1Department of Neurology, Medical Faculty Mannheim, Mannheim Center for Translational Neurosciences (MCTN), University of Heidelberg, Mannheim, Germany
2Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: katharina.sahm{at}umm.de
Tobias Kessler
3Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany
4Department of Neurology and Neurooncology Program, National Center for Tumor Diseases (NCT), Heidelberg University Hospital, Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philipp Eisele
1Department of Neurology, Medical Faculty Mannheim, Mannheim Center for Translational Neurosciences (MCTN), University of Heidelberg, Mannheim, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Philipp Eisele
Miriam Ratliff
5Department of Neurosurgery, Medical Faculty Mannheim, Mannheim Center for Translational Neurosciences (MCTN), University of Heidelberg, Mannheim, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elena Sperk
6Department of Radiation Oncology, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laila König
7Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael O. Breckwoldt
2Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany
8Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Corinna Seliger
4Department of Neurology and Neurooncology Program, National Center for Tumor Diseases (NCT), Heidelberg University Hospital, Heidelberg, Germany
9Wilhelm Sander-NeuroOncology Unit and Department of Neurology, Regensburg University Hospital, Regensburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Iris Mildenberger
1Department of Neurology, Medical Faculty Mannheim, Mannheim Center for Translational Neurosciences (MCTN), University of Heidelberg, Mannheim, Germany
2Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Schrimpf
10Department of Neuropathology, Heidelberg University Hospital, Heidelberg, Germany
11Clinical Cooperation Unit Neuropathology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christel Herold-Mende
12Division of Experimental Neurosurgery, Department of Neurosurgery, Heidelberg University Hospital, Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pia S. Zeiner
13Dr Senckenberg Institute of Neurooncology, University of Frankfurt, Frankfurt, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Pia S. Zeiner
Ghazaleh Tabatabai
14Department of Neurology & Interdisciplinary Neurooncology, University Hospital Tübingen, Hertie Institute for Clinical Brain Research, Eberhar Karls University Tübingen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sven G. Meuth
15Department of Neurology, Institute of Translational Neurology, University Hospital Münster, Münster, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Capper
16Department of Neuropathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany
17German Cancer Consortium (DKTK), Partner Site Berlin, German Cancer Research Center, Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin Bendszus
8Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andreas von Deimling
10Department of Neuropathology, Heidelberg University Hospital, Heidelberg, Germany
11Clinical Cooperation Unit Neuropathology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wolfgang Wick
3Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany
4Department of Neurology and Neurooncology Program, National Center for Tumor Diseases (NCT), Heidelberg University Hospital, Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Felix Sahm
10Department of Neuropathology, Heidelberg University Hospital, Heidelberg, Germany
11Clinical Cooperation Unit Neuropathology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Felix Sahm
Michael Platten
1Department of Neurology, Medical Faculty Mannheim, Mannheim Center for Translational Neurosciences (MCTN), University of Heidelberg, Mannheim, Germany
2Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michael Platten
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Concurrent malignant brain tumors in patients with multiple sclerosis (MS) constitute a rare but paradigmatic phenomenon for studying neuroimmunological mechanisms from both molecular and clinical perspectives.

Methods A multicenter cohort of 26 patients diagnosed with both primary brain tumors and multiple sclerosis was studied for disease localization, tumor treatment-related MS activity, and molecular characteristics specific for diffuse glioma in MS patients.

Results MS neither predisposes nor protects from the development of gliomas. Patients with glioblastoma WHO grade IV without IDH mutations had a longstanding history of MS, whereas patients diagnosed with IDH-mutant astrocytoma WHO grade II received multiple sclerosis diagnosis mostly at the same time or later. Concurrent MS was associated with a lesser extent of tumor resection and a worse prognosis in IDH-mutant glioma patients (PFS 32 vs. 64 months, p=0.0206). When assessing tumor-intrinsic differences no distinct subgroup-defining methylation pattern was identified in gliomas of MS patients compared to other glioma samples. However, differential methylation of immune-related genetic loci including human leukocyte antigen locus on 6p21 and interleukin locus on 5q31 was found in MS patients vs. matched non-MS patients. In line, inflammatory disease activity increased in 42% of multiple sclerosis patients after brain tumor radiotherapy suggesting a susceptibility of multiple sclerosis brain tissue to pro-inflammatory stimuli such as ionizing radiation.

Conclusions Concurrent low-grade gliomas should be considered in multiple sclerosis patients with slowly progressive, expansive T2/FLAIR lesions. Our findings of typically reduced extent of resection in MS patients and increased MS activity after radiation inform future treatment decisions.

Key points

  • – Disease history and sequence of diagnosis differ in MS patients with high-vs low-grade glioma

  • – Gliomas of MS patients harbor subtle methylation changes in immune-related genetic regions

  • – Brain tumor radiotherapy is followed by MS disease activity

Importance of the study Immune escape is a hallmark of diffuse glioma, while inflammation is the underlying mechanism of multiple sclerosis. These opposing mechanisms concur in patients that suffer in parallel from multiple sclerosis and glioma. This study is the first to investigate the tumor characteristics, tumor treatment responses and effect on multiple sclerosis activity of a cohort of patients with both diseases. The data warrant caution in the interpretation of suspicious lesions in imaging and suggests risk loci for the observed detrimental effects of radiation specific to MS patients.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by a grant from the Deutsche Forschungsgemeinschaft (DFG) within CRC1366 Vascular Control of Organ Function, project number 39404578, to KS and MP (project C1) and the Hertie Foundation (P1200013) to KS. MOB acknowledges funding by the Else Kroener-Fresenius Stiftung (2019_EKMS.23).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Tissue sample collection and data collection and use were performed following local ethics regulations and approved by the local ethics committee of Heidelberg University (ethics votes 005/2003, 2013-832R-MA, 2018-614N-MA).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Funding: This work was supported by a grant from the Deutsche Forschungsgemeinschaft (DFG) within CRC1366 “Vascular Control of Organ Function”, project number 39404578, to KS and MP (project C1) and the Hertie Foundation (P1200013) to KS. MOB acknowledges funding by the Else Kröner-Fresenius Stiftung (2019_EKMS.23).

  • Conflict of interest: The authors declare that they have no competing interests.

  • Authorship: Conception and design: KS, MP. Acquisition of data: all. Analysis of data: KS, TK, DS, FS, MP. Interpretation of data: all. Writing, review, and/or revision of the manuscript: all.

Data Availability

All data produced in the present study are available upon reasonable request to the authors

  • Abbreviations

    CI
    confidence interval
    DMP
    differentially methylated position
    DMR
    differentially methylated region
    HLA
    human leukocyte antigen
    IDH
    isocitrate dehydrogenase
    IL
    interleukin
    MGMT
    O6-methylguanine-DNA methyltransferase
    NAWM
    normal appearing white matter
    OR
    odds ratio
    OS
    overall survival
    PFS
    progression-free survival
    RANO
    response assessment in neuro-oncology
    RT
    radiotherapy
    SVD
    singular value decomposition
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
    Back to top
    PreviousNext
    Posted July 04, 2022.
    Download PDF

    Supplementary Material

    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Concurrent gliomas in patients with multiple sclerosis
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Concurrent gliomas in patients with multiple sclerosis
    Katharina Sahm, Tobias Kessler, Philipp Eisele, Miriam Ratliff, Elena Sperk, Laila König, Michael O. Breckwoldt, Corinna Seliger, Iris Mildenberger, Daniel Schrimpf, Christel Herold-Mende, Pia S. Zeiner, Ghazaleh Tabatabai, Sven G. Meuth, David Capper, Martin Bendszus, Andreas von Deimling, Wolfgang Wick, Felix Sahm, Michael Platten
    medRxiv 2022.07.01.22277047; doi: https://doi.org/10.1101/2022.07.01.22277047
    Twitter logo Facebook logo LinkedIn logo Mendeley logo
    Citation Tools
    Concurrent gliomas in patients with multiple sclerosis
    Katharina Sahm, Tobias Kessler, Philipp Eisele, Miriam Ratliff, Elena Sperk, Laila König, Michael O. Breckwoldt, Corinna Seliger, Iris Mildenberger, Daniel Schrimpf, Christel Herold-Mende, Pia S. Zeiner, Ghazaleh Tabatabai, Sven G. Meuth, David Capper, Martin Bendszus, Andreas von Deimling, Wolfgang Wick, Felix Sahm, Michael Platten
    medRxiv 2022.07.01.22277047; doi: https://doi.org/10.1101/2022.07.01.22277047

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Neurology
    Subject Areas
    All Articles
    • Addiction Medicine (430)
    • Allergy and Immunology (755)
    • Anesthesia (221)
    • Cardiovascular Medicine (3288)
    • Dentistry and Oral Medicine (364)
    • Dermatology (277)
    • Emergency Medicine (479)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1169)
    • Epidemiology (13359)
    • Forensic Medicine (19)
    • Gastroenterology (898)
    • Genetic and Genomic Medicine (5147)
    • Geriatric Medicine (481)
    • Health Economics (782)
    • Health Informatics (3264)
    • Health Policy (1140)
    • Health Systems and Quality Improvement (1190)
    • Hematology (429)
    • HIV/AIDS (1017)
    • Infectious Diseases (except HIV/AIDS) (14622)
    • Intensive Care and Critical Care Medicine (912)
    • Medical Education (476)
    • Medical Ethics (127)
    • Nephrology (522)
    • Neurology (4919)
    • Nursing (262)
    • Nutrition (727)
    • Obstetrics and Gynecology (882)
    • Occupational and Environmental Health (795)
    • Oncology (2519)
    • Ophthalmology (723)
    • Orthopedics (280)
    • Otolaryngology (347)
    • Pain Medicine (323)
    • Palliative Medicine (90)
    • Pathology (543)
    • Pediatrics (1299)
    • Pharmacology and Therapeutics (550)
    • Primary Care Research (556)
    • Psychiatry and Clinical Psychology (4205)
    • Public and Global Health (7499)
    • Radiology and Imaging (1704)
    • Rehabilitation Medicine and Physical Therapy (1011)
    • Respiratory Medicine (980)
    • Rheumatology (479)
    • Sexual and Reproductive Health (497)
    • Sports Medicine (424)
    • Surgery (547)
    • Toxicology (72)
    • Transplantation (235)
    • Urology (205)